Xenobiotica

Papers
(The H4-Index of Xenobiotica is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
One small step in time, one giant leap for DMPK kind – a CRO perspective of the evolving core discipline of drug development24
Academic foreign compound metabolism – ‘ quo vadis ’?23
In vitro hepatic metabolism of the natural product quebecol19
Meeting report: oligonucleotide ADME workshop16
Diisononyl phthalate down-regulates the expression of antioxidant genes NFE2L2 , TXN , and TXNRD2 , while d14
Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver13
In vitro and in vivo preclinical pharmacokinetic characterization of aficamten, a small molecule cardiac myosin inhibitor12
Nrf2 signaling pathway studies in Drosophila melanogaster : parallel roles in human health and insect environmental responses12
An In silico model-based feasibility assessment of erlotinib long-acting injectable formulation for the management of metastatic non-small cell lung cancer11
Formaldehyde directly induces cytotoxicity in human lymphocytes through ROS formation, mitochondrial/lysosomal destruction and oxidative stress; analysis of the protective effects of crocin11
Formulation of apigenin-loaded solid lipid nanoparticles: characterisation, molecular docking, and anticancer assay10
Developmental stage and infection status may affect drug distribution in the prostate of rats10
The protective effect of linalool against carbon tetrachloride-induced testicular toxicity in rats10
Apigenin derivatives as promising norovirus RdRp inhibitors: insights from in silico docking and molecular dynamics studies10
0.23285794258118